Business Daily from THE HINDU group of publications
Friday, Apr 27, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals
Wockhardt clocks Rs 52-cr net in Q1

Our Bureau

Mumbai April 26 Wockhardt Ltd has posted a profit after tax of Rs 52 crore for the quarter ended March 31, 2007, compared with Rs 4.9 crore for the corresponding period in the previous year. Total income has increased from Rs 265.2 crore for the quarter ended March 31, 2006, to Rs 296.1 crore for the quarter ended March 31, 2007.

The company clocked a consolidated net profit at Rs 66 crore for the first quarter ended March 31, 2007, against a loss of Rs 3.7 crore in the corresponding period last year. Consolidated sales, at Rs 523 crore, showed a 49 per cent growth over the corresponding quarter of 2006.

"Wockhardt's first quarter results are a demonstration of our significant upsurge and turnaround in sales and profit. Our recent Irish acquisition has also been accretive to Wockhardt's profit," Wockhardt Chairman, Mr Habil Khorakiwala, said in a statement.

"Besides, our research efforts have shown remarkable success, a classic example of which was our filing of over 40 patents and the five approvals that we received in the past few weeks alone," the note said.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Reliance full year net tops Rs 10,000 crore


Cipla net down 34%
Wockhardt clocks Rs 52-cr net in Q1
Zydus Cadila full year net jumps 53%
Suven net up 24% in Q4
Siscol net sales up at Rs 213 cr in Q4
ABB net profit rises 69%
3i Info sets 1:1 bonus; net leaps 84% in Q4
United Bank net rises 30.7%
State Bank of Bikaner net zooms


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line